Respironics Respiratory Drug Delivery (uk) Ltd

POWER SEARCH PRICING

SOLUTIONS

respironics respiratory drug delivery (uk) ltd Company Information

Company Number

04005206

Next Accounts

Sep 2025

Directors

Louise Best

Mark Leftwich

Shareholders

philips uk ltd

Group Structure

View All

Industry

Manufacture of medical and dental instruments and supplies

Registered Address

ascent 1 aerospace boulevard, farnborough, GU14 6XW

Website

https://workspace14.smilehouse.com

respironics respiratory drug delivery (uk) ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD at £0 based on a Turnover of £0 and 0.94x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Respironics Respiratory Drug Delivery (uk) Ltd is a live company located in farnborough, GU14 6XW with a Companies House number of 04005206. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in May 2000, it's largest shareholder is philips uk ltd with a 100% stake. Respironics Respiratory Drug Delivery (uk) Ltd is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

There is insufficient data available to calculate a health check for Respironics Respiratory Drug Delivery (Uk) Ltd. Company Health Check FAQs

Health Rating0out of 5

0 Strong

0 Regular

0 Weak

Size

There is insufficient data available for this Key Performance Indicator!

Growth

There is insufficient data available for this Key Performance Indicator!

EXPORT

Respironics Respiratory Drug Delivery (Uk) Ltd's latest turnover from December 2023 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Respironics Respiratory Drug Delivery (Uk) Ltd has no employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2021	Dec 2020	Dec 2019
Turnover
Other Income Or Grants
Cost Of Sales
Gross Profit
Admin Expenses			5,134,000
Operating Profit			-5,134,000
Interest Payable
Interest Receivable
Pre-Tax Profit			-5,134,000
Tax
Profit After Tax			-5,134,000
Dividends Paid
Retained Profit			-5,134,000
Employee Costs
Number Of Employees	1	1
EBITDA*			-5,134,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
total assets
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
net assets
total shareholders funds

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit					-5,134,000
Depreciation
Amortisation
Tax
Stock
Debtors
Creditors
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations					-5,134,000
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue					5,134,000
interest
cash flow from financing					5,134,000
cash and cash equivalents
cash
overdraft
change in cash

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for respironics respiratory drug delivery (uk) ltd. Get real-time insights into respironics respiratory drug delivery (uk) ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for respironics respiratory drug delivery (uk) ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in GU14 area or any other competitors across 12 key performance metrics.

RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD group structure

Respironics Respiratory Drug Delivery (Uk) Ltd has no subsidiary companies.

Ultimate parent company

KONINKLIJKE PHILIPS NV

#0079559

PHILIPS U.K. LIMITED

01927665

2 parents

RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD

04005206

RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD Shareholders

philips uk ltd

100%

Respironics Respiratory Drug Delivery (Uk) Ltd currently has 2 directors. The longest serving directors include Mrs Louise Best (Jul 2016) and Mr Mark Leftwich (Apr 2022).

officer	country	age	start	end	role
Mrs Louise Best	England	44 years	Jul 2016	-	Director
Mr Mark Leftwich	England	46 years	Apr 2022	-	Director

P&L

December 2023

turnover

operating profit

gross margin

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

total assets

cash

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

company number

04005206

Type

Private limited with Share Capital

industry

32500 - Manufacture of medical and dental instruments and supplies

incorporation date

May 2000

ultimate parent company

KONINKLIJKE PHILIPS NV

previous names

profile drug delivery limited (June 2005)

p t drug delivery limited (January 2002)

address

ascent 1 aerospace boulevard, farnborough, GU14 6XW

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to respironics respiratory drug delivery (uk) ltd. Currently there are 1 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD. This can take several minutes, an email will notify you when this has completed.

respironics respiratory drug delivery (uk) ltd Company Information

respironics respiratory drug delivery (uk) ltd Estimated Valuation

respironics respiratory drug delivery (uk) ltd Estimated Valuation

respironics respiratory drug delivery (uk) ltd Estimated Valuation

Respironics Respiratory Drug Delivery (uk) Ltd Overview

Respironics Respiratory Drug Delivery (uk) Ltd Health Check

RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD financials

respironics respiratory drug delivery (uk) ltd Credit Report and Business Information

Respironics Respiratory Drug Delivery (uk) Ltd Competitor Analysis

respironics respiratory drug delivery (uk) ltd Ownership

respironics respiratory drug delivery (uk) ltd directors

respironics respiratory drug delivery (uk) ltd company details

respironics respiratory drug delivery (uk) ltd Charges & Mortgages

respironics respiratory drug delivery (uk) ltd Capital Raised & Share Issues BETA

respironics respiratory drug delivery (uk) ltd Companies House Filings - See Documents